Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced glycation end products as environmental risk factors for the development of type 1 diabetes.

Current drug targets - 1 Apr 2012

Yap Felicia Y T, Kantharidis Phillip, Coughlan Melinda T, Slattery Robyn, Forbes Josephine M

Abstract excerpt

The globally rising incidence of Type 1 diabetes (T1D) is no longer restricted to individuals with higher risk genotypes, but is now significantly increasing in a population with lower risk genotypes, likely as the result of environmental factors. In this review, we discuss the potential of advanced glycation end products (AGEs) as environmental contributors to the development of T1D. AGEs are nonenzymatically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Diabetes Mellitus, Type 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Environmental Exposure

Share to Glycation End Products, Advanced

Share to Insulin-Secreting Cells

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Share to Risk Factors

Source

Identifiers

PMID: 22250649
DOI: 10.2174/138945012799499758

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced glycation end products as environmental risk factors for the development of type 1 diabetes.PMID 22250649Read ↗

Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.Semantic proximity Read ↗

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Semantic proximity Read ↗

A Role for Advanced Glycation End Products in Molecular AgeingSemantic proximity Read ↗

Genetic variability in the RAGE gene: possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications.Semantic proximity Read ↗

Risk factors and primary prevention trials for type 1 diabetes.Semantic proximity Read ↗

The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children.Semantic proximity Read ↗

Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?Semantic proximity Read ↗

Environmental trigger(s) of type 1 diabetes: why so difficult to identify?Semantic proximity Read ↗

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes.Semantic proximity Read ↗

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE conceptSemantic proximity Read ↗

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.Semantic proximity Read ↗

Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.